CLL Empirical Antibiotic Regimen
The purpose of this study is to evaluate whether patients with previously untreated, early stage CLL respond to empirical broad spectrum antibiotics and therefore test the hypothesis that occult bacterial infections are involved in the induction and maintenance of CLL.
Chronic Lymphocytic Leukaemia (CLL)
DRUG: metronidazole, clarithromycin, ciprofloxacin and lansoprazole
Overall response rate [Complete Remission (CR) + Partial Remission (PR)], 6 months
Incidence of CTCAE grade 2 or above treatment related toxicity, From day 1 to 6 weeks|Bone marrow Minimal Residual Disease (MRD) status in patients who achieve CR, 6 months
The purpose of this study is to evaluate whether patients with previously untreated, early stage CLL respond to empirical broad spectrum antibiotics and therefore test the hypothesis that occult bacterial infections are involved in the induction and maintenance of CLL.